CASE.EDU:    HOME | DIRECTORIES | SEARCH
case western reserve university

DEPARTMENT OF MEDICINE

 
 

W. Henry Boom, M.D.

Professor of Medicine
Vice Chair for Research, Department of Medicine
Director, Tuberculosis Research Unit


Education

M.D. University of Rochester, 1979
Infectious Disease Fellowship, Massachusetts General Hospital, Harvard School of Public Health and Brigham and Women’s Hospital, 1983 -1988
Internal Medicine Residency and Chief Residency, George Washington University Medical Center, 1979-1983


Office 216-368-4844
Email whb@case.edu


Research Area

Tuberculosis


Research

T cells play a critical role in the immune response to the intracellular pathogen M. tuberculosis, which is estimated to infect one third of the world's population. T cells regulate the acquired immune response which controls primary infection and provide protection against exogenous reinfection. CD4+ T cells traditionally have been considered the main T cell subset responsible for regulating protective immune responses to M. tuberculosis. However, in addition to the CD4+ T cell, both gamma-delta T cell receptor bearing T cells (gamma delta cells) and CD8+ T cells have a role in protective immunity to M. tuberculosis. The study of CD4+, CD8+ and gamma delta T cell responses to M. tuberculosis is the main interest of my laboratory.

The focus is on characterization of mycobacterial antigens recognized by CD4+ and gamma-delta T cells, the role of cytokines such as IL-2, IL-12, IFN-gamma, IL-10 and TGF-beta in modulating the T cell responses to M. tuberculosis, the functional interaction of antigen-specific T cells with macrophages infected with mycobacteria, and the mechanisms used by M. tuberculosis infected macrophages to process and present antigens from the phagosome to the cell surface to these different T cell subsets. Recent studies have focused on identifying molecules of M. tuberculosis that interfere with MHC-II antigen processing. Specifically the role of mycobacterial lipoproteins and TLR receptors in regulating MHC-II antigen processing has become a major focus.

These studies use cellular immunological and cell biologic approaches to study the biology of M. tuberculosis infected macrophages and T cells. In addition, a murine in vivo model of M. tuberculosis infection of the lung is used to study the unique micro-environment where M. tuberculosis infection occurs and immune responses are initiated.

Selected Publications

• Ramachandra L, Noss EN, Boom WH, Harding CV (2001) Processing of M. tuberculosis antigen 85B involves intra-phagosomal formation of peptide:MHC-II complexes and is inhibited by live bacilli that decrease phagosome maturation. J Exp Med 194, 1421-1432.

• Rojas RE, Torres M, Fournie JJ, Harding CV, Boom WH (2002) Phosphoantigen presentation by macrophages to M. tuberculosis – reactive Vgamma9Vdelta2 + T cells: modulation by Chloroquine. Infection and Immunity 70, 4019-4027.

• Pai RK, Askew D, Boom WH, Harding CV (2002) Regulation of Class II Major histocompatability complex expression in professional antigen presenting cells: role of types I, III, IV class II transactivator. J Immunology 169, 1326-1333.

• Canaday D, Beigi R, Silver RF, Harding CV, Boom WH*, Dubyak GR* (2002) ATP and control of intracellular growth of mycobacteria by T cells. Infection and Immunity 70, 6456-6459. *Joint Senior Authorship

 
 
 

© 2004 Case Western Reserve University | Cleveland, Ohio 44106 | 216.368.2000 | legal notice